SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-103867
Filing Date
2024-09-30
Accepted
2024-09-30 06:07:42
Documents
13
Period of Report
2024-09-27
Items
Item 5.08: Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2425163d1_8k.htm   iXBRL 8-K 27690
  Complete submission text file 0001104659-24-103867.txt   199738

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION LABEL LINKBASE qnrx-20240927_lab.xml EX-101.LAB 34240
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qnrx-20240927_pre.xml EX-101.PRE 22365
4 XBRL TAXONOMY EXTENSION SCHEMA qnrx-20240927.xsd EX-101.SCH 3024
15 EXTRACTED XBRL INSTANCE DOCUMENT tm2425163d1_8k_htm.xml XML 3634
Mailing Address 23 HATA'AS STREET KFAR SABA L3 44425
Business Address 23 HATA'AS STREET KFAR SABA L3 44425 97299741444
Quoin Pharmaceuticals, Ltd. (Filer) CIK: 0001671502 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3
Type: 8-K | Act: 34 | File No.: 001-37846 | Film No.: 241336471
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)